These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38236162)

  • 21. Matrix metalloproteinases in plants: a brief overview.
    Marino G; Funk C
    Physiol Plant; 2012 May; 145(1):196-202. PubMed ID: 22084906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
    Chen Y; Peng W; Raffetto JD; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dual personalities of matrix metalloproteinases in inflammation.
    Le NT; Xue M; Castelnoble LA; Jackson CJ
    Front Biosci; 2007 Jan; 12():1475-87. PubMed ID: 17127395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS).
    Łukaszewicz-Zając M; Mroczko B; Słowik A
    J Neural Transm (Vienna); 2014 Nov; 121(11):1387-97. PubMed ID: 25047909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis.
    Zhang D; Samani AA; Brodt P
    Horm Metab Res; 2003; 35(11-12):802-8. PubMed ID: 14710361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease.
    Zakiyanov O; Kalousová M; Zima T; Tesař V
    Adv Clin Chem; 2021; 105():141-212. PubMed ID: 34809827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling.
    Chen Q; Jin M; Yang F; Zhu J; Xiao Q; Zhang L
    Mediators Inflamm; 2013; 2013():928315. PubMed ID: 23840100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Roles of MT1-MMP and MMP-2: Beyond the Extracellular Milieu.
    Maybee DV; Ink NL; Ali MAM
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinases in atherothrombosis.
    Bäck M; Ketelhuth DF; Agewall S
    Prog Cardiovasc Dis; 2010; 52(5):410-28. PubMed ID: 20226959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
    Fink K; Boratyński J
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A specific subset of RabGTPases controls cell surface exposure of MT1-MMP, extracellular matrix degradation and three-dimensional invasion of macrophages.
    Wiesner C; El Azzouzi K; Linder S
    J Cell Sci; 2013 Jul; 126(Pt 13):2820-33. PubMed ID: 23606746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells.
    Sbai O; Ferhat L; Bernard A; Gueye Y; Ould-Yahoui A; Thiolloy S; Charrat E; Charton G; Tremblay E; Risso JJ; Chauvin JP; Arsanto JP; Rivera S; Khrestchatisky M
    Mol Cell Neurosci; 2008 Dec; 39(4):549-68. PubMed ID: 18817873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of proteinases and inhibitors in human breast cancer progression and survival.
    Baker EA; Stephenson TJ; Reed MW; Brown NJ
    Mol Pathol; 2002 Oct; 55(5):300-4. PubMed ID: 12354933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R; Nagase H
    Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes.
    Sbai O; Ould-Yahoui A; Ferhat L; Gueye Y; Bernard A; Charrat E; Mehanna A; Risso JJ; Chauvin JP; Fenouillet E; Rivera S; Khrestchatisky M
    Glia; 2010 Feb; 58(3):344-66. PubMed ID: 19780201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in invasion of tumours of neuroepithelial tissue].
    Bogaczewicz J; Jasielski P; Mosiewicz A; Trojanowski T; Suchozebrska-Jesionek D; Stryjecka-Zimmer M
    Neurol Neurochir Pol; 2006; 40(5):404-12. PubMed ID: 17103354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.
    Chaudhary AK; Singh M; Bharti AC; Asotra K; Sundaram S; Mehrotra R
    J Biomed Sci; 2010 Feb; 17(1):10. PubMed ID: 20152059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.